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Abstract: This study evaluated the effectiveness of strategies used to recruit and retain overweight,
inactive adults with intermediate hyperglycaemia (IHG) to a novel walking programme. Participant
compliance to the nine-month randomised controlled trial (RCT) is also presented. Inactive over-
weight (BMI ≥ 25 kg/m2) adults (N = 42; n = 19 male, n = 23 female) aged between 18–65 years, with
IHG were identified via three recruitment strategies (NHS database reviews, diabetic clinics, and
a University population). Participants were randomly assigned to either Intervention Group (IG
n = 22; n = 11 male, n = 11 female) or Usual Care (UC n = 20; n = 8 male, n = 12 female). IG followed a
nine-month novel behaviour change intervention where they walked in accordance with physical
activity guidelines using the beat of music to maintain appropriate cadence. UC received standard
physical activity advice. Recruitment, retention, and intervention compliance were calculated using
descriptive statistics (means or frequencies). Recruiting from a University population was the most
successful strategy (64.2% response rate) followed by NHS database reviews (35.8%) and then diabetic
clinics (0%). Study retention was ≥80% in both groups throughout the RCT. Intervention compliance
was highest from baseline to four months (70.1 ± 39.2%) and decreased as the study progressed
(43.4 ± 56.1% at four to six months and 37.5 ± 43.5% at follow-up). In total, 71.4% of IG walking
completed throughout the study was at least moderate intensity. A novel walking intervention incor-
porating the use of music along with behaviour change techniques appears to positively influence
the recruitment, retention, and walking compliance of this population.
Keywords: overweight; intermediate hyperglycaemia; prediabetes; walking; physical activity;
behaviour change; recruitment strategies; retention; compliance
1. Introduction
IHG is a hyperglycaemic state which is sufficient to cause glucometabolic dysfunction
in target tissues, however due to its asymptomatic nature, hyperglycaemia often remains
clinically undiagnosed before type 2 diabetes is identified [1]. As individuals with IHG are
often unaware they have the pre-disease condition, identification and recruitment of this
population is difficult. Furthermore, as IHG is usually asymptomatic and is considered
an intermediate state rather than a disease [1,2], once diagnosed the severity and risks
associated with the condition are often overlooked or generally underestimated by sufferers.
IHG is not only associated with impaired glycaemic function but is also associated with
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other comorbidities and risks. A constant state of hyperglycaemia can cause glucometabolic
dysfunction leading to damaged organs associated with cardiovascular disease including
the heart and its blood vessels [3,4]. In overweight populations during the intermediate
state, adaptations in response to chronic exposure to excess adipose tissue may cause
impaired glucometabolic responses, increased oxidative stress, increased inflammation,
endothelium dysfunction as well as impaired behavioural and psychological effects [4–9].
It is therefore salient that IHG sufferers are identified to reduce the risk of type 2 diabetes
and developing associated comorbidities.
Quantifying the extent of this problem remains difficult. Most recent figures estimate
that approximately 88 million US adults, more than one in three, meet the diagnostic
criteria for IHG [10]. Prevalence within the Irish adult population is estimated at 18.7% [11].
The Diabetes Mellitus and Vascular health initiative (DMVhi) screened 29,144 adults aged
45–75 years in the Republic of Ireland results identified undetected abnormal glucose in at
least 11.8% of Irish adults aged 45–75 years [12]. In the UK, around seven million people
are projected to have IHG [2,13] and it is now estimated that in England one in every three
people have IHG [2,14]. Overweight and obesity increase the risk of developing type 2
diabetes by 80–85% [15]. Six in ten Irish Adults are overweight or obese (37% overweight
and a further 23% obese) and in the UK 66.6% of men and 57.2% of women were reported
as overweight or obese in 2014 [16–18]. It is well established that increasing physical
activity behaviour within overweight adults with IHG is one method to reduce the risk of
developing glucometabolic and cardiovascular disease complications [2,4,19]. However,
difficulties regarding the identification and recruitment of this significant population must
be explored.
Once individuals become aware of their IHG condition and are recruited onto physical
activity interventions, further challenges include retention, maintenance, and compliance.
A recent systematic review and meta-analysis highlighted when assessing physical activity
intervention feasibility, group differences in outcomes should be supported by reporting
adoption, maintenance, adherence (compliance), and retention rates [20]. Therefore, inter-
vention effectiveness should consider both the changes in outcome measures in addition to
the implementation of physical activity interventions within the real world [20]. Reporting
of additional study effectiveness rates along with changes in outcome measures would
enable researchers to fully understand the real-world effectiveness of physical activity
interventions. This study aims to report the strategies used to recruit overweight inactive
adults with IHG to a free-living walking intervention with behaviour change support. This
work also presents study retention and compliance to the novel free-living walking to
music programme.
2. Materials and Methods
2.1. Participants
Inactive overweight (BMI ≥ 25 kg/m2) adults aged between 18–65 years, with IHG
were recruited via one of the recruitment processes outlined below. The study was con-
ducted in accordance with the Declaration of Helsinki, and ethical approval was received
from the Ulster University Research Ethics Filter Committee and the Office for Research
Ethics Committees in Northern Ireland (Approval number: 12/NI/0063, 21 June 2012).
2.2. Study Phase One: Recruitment Strategies
I. NHS Database Reviews: A review of previous oral glucose tolerance tests (OGTTs)
completed within the South Eastern Health and Social Care Trust (SEHSCT) and the
Western Health and Social Care Trust (WHSCT) in the previous three years (21 June 2010
and 20 May 2013) was performed. Following review, individuals who met the diagnostic
criteria (fasting glucose 5.6–6.9 mmol/L−1 and/or two-hour glucose 7.8–11.0 mmol/L−1)
were invited to take part by postal correspondence.
II. Diabetic Clinics: Recruitment from diabetic clinics based at the Ulster Hospital
and Altnagelvin Area Hospital was conducted by the relevant consultant or designated
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nurse. The relevant health professional made initial contact with potential participants who
were referred to the clinics due to their risk of developing type 2 diabetes because of being
overweight, obese or with a family history of type 2 diabetes. Individuals were verbally
advised about the study and offered a participant information sheet with the researchers
contact details if they wished to receive further information.
III. University Population: Overweight University staff and student volunteers
(BMI ≥ 25 kg/m2; across all Ulster University campuses) were recruited via email, poster,
and word-of-mouth. Following an initial consultation interested individuals were invited
to take part in Study Phase Two. If participants met the diagnostic criteria (fasting glu-
cose 5.6–6.9 mmol/L−1 and/or two-hour glucose 7.8–11.0 mmol/L−1) a final screening
letter aligned with study inclusion and exclusion criteria was sent to their G.P. to confirm
suitability to participate in the research.
Following recruitment (by all 3 methods) interested individuals received a participant
information sheet. Participants were required to provide informed consent and complete
screening documents including a health history questionnaire before being invited to take
part in the second phase of the study (glucometabolic and anthropometric measures). At
this point participants completed a preferred choice of communication form to indicate
their preferred time and mode of communication (telephone call, mobile phone call, SMS
message, letter via post or email) throughout the study. Individuals were excluded if they
had progressed to type 2 diabetes, returned to normoglycaemia or were aged ≤18 years of
age or ≥65 years of age at inception of the study. Individuals with a history of cardiovascu-
lar disease events or an illness which would contraindicate participation in the intervention
were not permitted to take part in the study. Finally, smokers or individuals prescribed
medication which may interfere with blood biochemistry were excluded.
2.3. Study Phase Two: Glucometabolic and Anthropometric Status
Following expression of interest and providing informed consent, participants were
invited to attend a screening to ensure their blood glucose response met the diagnos-
tic criteria for the study (fasting glucose 5.6–6.9 mmol/L−1 and/or two-hour glucose
7.8–11.0 mmol/L−1; see Glucometabolic Status below). Individual height (cm), body mass
(kg) and BMI (kg/m2) were also assessed to ensure participants had a BMI ≥ 25 (see
Anthropometric Measurements below). Study Phase two took place either at their local hospital
or at the Ulster University Human Performance Laboratory.
2.3.1. Glucometabolic Status
Fasted venous blood samples were collected following an overnight fast (at least eight
hours) and 24 h rest from vigorous physical activity. Blood samples were collected via
venepuncture method in a 2 mL sodium fluoride K3EDTA blood tube to inhibit glycolysis.
Fasting plasma glucose (mmol/L−1) samples were analysed using the UV test principle.
Participants with fasting plasma glucose 5.6–6.9 mmol/L−1 (110–125 mg/dL) underwent
an OGTT to determine glucose tolerance status using standard methods [21,22].
2.3.2. Anthropometric Measurements
Height (cm) and body mass (kg) were recorded using a freestanding stadiometer
(Holtain Ltd, Crymych, UK) and scales, respectively (Seca delta, Hamburg, Germany).
Measurements were completed wearing light clothing, without footwear and in a fasted
state. Height (cm) and body mass (kg) were recorded to the nearest 0.1 cm and 0.1 kg,
respectively. BMI (kg/m2) was calculated for all participants at each assessment time point
using the following equation [23]. BMI (kg/m2) = Body mass (kg)/Height (m2).
2.4. Study Phase Three: Physical Activity
To ensure participants were inactive, all individuals wore an Actigraph GT3X ac-
celerometer (Actilife, Pensacola, FL, USA) for all waking hours on seven consecutive days
to assess physical activity behaviour. This study employed the Freedson et al. activ-
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ity cut-points for adults [24]. Devices were initialised with a start and end time of one
week or seven days in duration. Non-wear periods were defined as 60 min or more of
consecutive zeros. Similar to previous research sleep periods were ignored and consid-
ered non-wear time [25] ≥10 h of wear time was considered a valid day. The minimum
number of valid days required was three days [26]. Time in sedentary behaviour was
defined as 0–99 activity counts per minute (cpm). Time in light intensity was defined
as 100–1951 activity cpm. A total of 1952–5724 activity cpm was considered moderate
intensity activity and 5725–9498 activity cpm was considered vigorous intensity activity.
≥9499 activity cpm was considered very vigorous intensity activity.
2.5. Study Phase Four: Participant Randomisation and Experimental Design
When participants satisfied Study Phase Two and Three criteria a blinded third-party
researcher randomly assigned participants (Figure 1) to either IG or UC. To reduce the
risk of researcher bias, the name of the designated group was placed in a sealed opaque
envelope which the participant then chose at random. IG participants received an individ-
ualised progressive weekly walking programme designed to increase moderate intensity
walking to 30 min per day based on current physical activity guidelines for health [27]. IG
participants used an MP3 music player (iPod touch 4, Apple Inc., Cupertino, CA, USA) with
individually selected music set to a predetermined beat to regulate walking cadence [5].
Music tempo was individually established in accordance with previous height-related
stride rate recommendations determined by Rowe and colleagues [28] to elicit moderate
intensity exercise for each individual (50–70% maximum heart rate: 90–113 steps/min−1).
The MP3 device was held in a case attached to a waistband. IG participants were in-
structed on how to use and store the data and MP3 device throughout the study. Cadence
(steps/min−1) was recorded and saved through the use of the inbuilt accelerometer and
app and later analysed via a Matlab application (MATLAB, The MathWorks Inc., Natick,
MA, USA, 2014). UC received the standard or ‘usual care’ they would receive from their
local health professional. This consisted of a standard physical activity information sheet
only [27]. The intervention was completed over a 19-month period. The first participant
was randomised onto the study in August 2012, with the final participant completing the
nine-month intervention in March 2014.
Assessment of RCT outcome measures included a range of clinical, physiological and
behaviour change parameters at baseline, four, six and nine (follow-up) months as outlined
in Figure 1 (full details of outcome measures are available in a previous publication [5]). At
baseline, four- and six-month assessments, the IG participants received physical activity
consultations. Between assessment points IG participants received booster sessions via
their preferred mode of contact identified during Study Phase Two (Figure 1) [5] and were
asked to complete their walking programme to music (an overview of behaviour change
techniques and strategies used was previously published [5]). UC participants received
no contact between assessments. At the end of the programme the UC participants were
offered a three-month walking programme.
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Figure 1. Outline of the RCT delivery and assessment time points at baseline, four, six and nine (follow-up) months. 
2.6. Sample Size and Statistical Analysis 
In order to detect a difference of 1.0 mmol/L−1 in two-hour glucose levels between the 
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calculation was based on a statistical power of 80%, a significance of 0.05, and a SD of 1.0 
mmol/L−1. This power calculation also allowed for 50% dropout rate (non-completers and 
participants who develop type 2 diabetes) [29]. Therefore, to achieve statistical power at 
least 16 participants per group were required to complete the six-month intervention. 
Participant recruitment and retention rates were calculated using descriptive statis-
tics (means or frequencies). IG % walk compliance (volume and duration) was assessed 
by comparing the app recorded walks to walking prescribed in each programme. Walking 
intensity compliance was assessed by calculating the percentage of walks that, on average, 
were completed at or above the predetermined target cadence. An Independent Samples 
t-test was used to examine differences between groups at baseline (p < 0.05). All data were 
presented as mean value ± standard deviation or percentages. All statistical analysis was 
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analysis was carried out using Microsoft Excel and SPSS version 22.0 for Windows (SPSS,
Chicago, IL, USA).
3. Results
3.1. Recruitment and Randomisation
Following patient database searches n = 305 invitation letters (n = 256 SEHSCT,
n = 49 WHSCT) were posted to suitable individuals who met the diagnostic criteria (fasting
glucose 5.6–6.9 mmol/L−1 and/or two-hour glucose 7.8–11.0 mmol/L−1). Recruitment
strategy one (NHS database reviews) resulted in n = 49 (n = 43 SEHSCT, n = 6 WHSCT)
individuals expressing interest in taking part in the study. These individuals were invited
to take part in Study Phase Two to ensure they met the study inclusion criteria. Overall
response rate for recruitment strategy one was 16.1% (16.8% SEHSCT, 12.2% WHSCT). No
participants (n = 0; 0%) were recruited from recruitment strategy two (Clinician led diabetic
clinics). Recruitment strategy three (University population) generated n = 88 interested
responses. Following an initial consultation these individuals (n = 88) were invited to take
part in Study Phase Two. Overall, 137 responses were received from recruitment strategy
one (n = 49), two (n = 0) and three (n = 88). Recruitment strategy three achieved the greatest
response rate (64.2%). Recruitment strategy one accounted for 35.8% of overall responses
(31.4% SEHSCT; 4.4% WHSCT) and recruitment strategy two resulted in no responses (0%).
Figure 2 provides an overview of the recruitment strategies and randomisation procedures.
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63.5% (n = 87) of respondents to Study Phase One (n = 137) accepted the invitation to com-
plete Study Phase Two and Three to ensure they met the study inclusion criteria (Figure 2). Study
Phase Three found approximately 65% of participants’ typical days (10 h) were spent in seden-
tary activity (≤100 cpm), 33% spent in light intensity activity (100–1951 cpm), 3% was spent
in moderate intensity activity (1952–5724 cpm) and only 0.12% and 0.01% spent in vigorous
intensity (5725–9498 cpm) and very vigorous intensity activity (≥9499 cpm), respectively.
48.3% (N = 42; IG n = 22, 50% (n = 11) male, 50% (n = 11) female; UC n = 20, 36.4%
(n = 8) male, 54.6% (n = 12) female) of participants invited to complete Study Phase Two and
Three met the inclusion criteria and were randomised onto the study (Study Phase Four).
Ethnicity ranged within groups (IG 95% Caucasian and 5% Asian; UC participants 95%
Caucasians and 5% Asian). No significant differences were observed between groups at
baseline (p > 0.05; see Table 1 for participants’ baseline characteristics).
Table 1. Overall and group baseline descriptives following randomisation. M = mean, SD = standard deviation,
Min = minimum range, Max = maximum range, FPG = fasting plasma glucose, 2 h Gluc = two-hour glucose concen-
tration. Independent Samples t-test found no statistically significant differences between groups at baseline (p > 0.05).
Parameter
Overall Participants (n = 42) IG Participants (n = 22) UC Participants (n = 20)
M SD Min Max M SD Min Max M SD Min Max
BMI (kg/m2) 33.26 5.82 24.70 50.54 33.59 5.89 26.75 48.60 32.90 5.89 24.7 50.54
Body mass (kg) 94.41 16.62 60.80 127.60 95.19 15.32 61.40 122.70 93.56 18.32 60.80 127.60
Height (cm) 168.55 9.14 151.50 186.50 168.56 9.29 151.50 186.50 168.53 9.20 156.40 182.50
FPG (mmol/L−1) 6.20 0.58 5.20 8.30 6.20 0.70 5.20 8.30 6.21 0.45 5.60 6.90
2 h Gluc
(mmol/L−1) 8.28 3.17 3.40 17.30 8.45 3.63 3.40 17.30 8.09 2.67 4.10 14.60
Age (years) 49.96 12.16 19.80 64.50 49.15 9.78 19.80 61.60 50.68 14.18 21.90 64.50
3.2. Study Retention
Participants were randomly assigned to an IG (n = 22) or UC group (n = 20) as
part of the nine-month walking intervention (Figure 3). Five participants (n = 5; IG
n = 5) who completed initial screening assessments only, i.e., OGTT (mmol/L−1), height
(cm), body mass (kg) and BMI (kg/m2) were excluded from other baseline measurements
due to an undisclosed cardiac event (n = 1), returning to normal glucose control (n = 1)
and progressing to type 2 diabetes (n = 3). Therefore, a total of 37 participants (n = 37)
progressed through the intervention (Figure 3). IG participants (n = 17) walked to self-
selected music with a predetermined tempo based upon Rowe et al. [28] height related
stride rate guidelines and received behavioural change support [5]. UC participants (n = 20)
received a standard PA information sheet only. Study retention rates are provided in Table 2.
Details of participant retention including exclusions and drop-outs are detailed in Figure 3.
Table 2. Outline of participant retention rates throughout the study.
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Six months 16 94.1 16 80 32 86.5
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compliance (volume and duration) at follow-up was recorded as 37.5 ± 43.5% (range 0%
to 125.3%). In total, 71.4%, 79.5% and 73.3% of walking completed was at least moderate
intensity (predetermined target cadence) between baseline to four months, four to six
months and six to nine months, respectively.
4. Discussion
This study describes the effectiveness of the strategies used to recruit overweight,
inactive adults with IHG to a nine-month free-living walking and behaviour change RCT.
Participant retention and intervention compliance were also examined. This study found
that recruiting from a University population achieved the highest response rate accounting
for 64.2% of responses received. Overall study retention rates were ≥80% in both groups
throughout the RCT. Intervention compliance (volume and duration) was highest from
baseline to four months (70.1 ± 39.2%) and decreased as the study progressed (43.4 ± 56.1%
four to six months and 37.5 ± 43.5% six months to follow-up). Interestingly, ≥71.4%
of walking completed was at least moderate intensity (predetermined target cadence)
throughout the nine-month study. These latter results suggest walking to music with
a predetermined individualised tempo may provide a novel method that enables this
population to achieve moderate intensity activity in a free-living environment.
Several key issues exist when planning trials involving IHG participants. Identification
of this asymptomatic population is the initial challenge faced by researchers and clinicians.
Furthermore, as IHG is largely asymptomatic and is considered an intermediate state rather
than a disease [1], once diagnosed, the severity and risks associated with the condition
are often overlooked or generally underestimated by those affected. Thus, recruiting such
‘unaware’ high risk participants proves problematic. This study used three recruitment
strategies in an effort to achieve a sufficient sample size. Recruiting through email and
poster advertisements within the University setting (recruitment strategy three) was the
most productive approach achieving almost two thirds of study responses (64.2%). NHS
databases were reviewed (recruitment strategy one), and once suitable individuals were
identified based on their fasting plasma glucose and/or OGTT records, invitation letters
(n = 305) were posted. Following this lengthy process, a response rate of 16.1% (n = 49)
was achieved. This contributed to approximately one third (35.8%) of the overall study
response rate. No participants (n = 0, 0%) were recruited from recruitment strategy two
(Clinician led recruitment via diabetic clinics). A recent review found overall recruitment
rates of minority populations (South Asian) in behavioural interventions to improve type
2 diabetes outcomes were low [30]. Twelve studies had a mean recruitment rate of 44%
among those screened, and nine studies with complete information on eligibility had a
mean recruitment rate of 65.8% among those eligible [30]. Horowitz and colleagues [31]
used community-based participatory research to compare the effectiveness of different
strategies in recruiting and enrolling adults with prediabetes into a peer-led diabetes
prevention intervention. Similar to the current study that used a campus-based researcher
to recruit from the University population, the partner-led approach in which community
partners developed and managed the recruitment efforts at their sites was most successful,
recruiting 68% of people enrolled [31]. This was also the most efficient strategy with 34%
of those approached through partners ultimately enrolled, versus 0–17% through the other
four strategies (recruiting through clinicians, at large public events, organising special local
recruitment events and recruiting at local organisations) [31]. These researchers highlighted
the value of a partner-led recruitment to identify, reach out and motivate a vulnerable
population into research, using techniques that may be unfamiliar to researchers, but are
nevertheless rigorous and effective [31].
Once this at-risk population have been identified the challenge of ensuring participants
are retained continue. Additionally, maintaining long term physical activity change in
a free-living environment proves problematic. Study retention rates were ≥80% in both
groups throughout this RCT. Dissatisfaction following the randomisation process often
attributes to large drop-out rates of control group participants in trials [32]; however, in the
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current study UC retention rates were 80% throughout the nine-months. Not unusually
study retention rates were higher for IG participants compared to UC participants at each
assessment point (94.1% vs. 80% four months, 94.1% vs. 80% six months, and 88.3%
vs. 80% nine months, respectively; Table 2). This may be attributed to the behavioural
change support and novel techniques (walking to music via use of an app) used to facilitate
IG participants to achieve and maintain the walking programme. Another potential
contributing factor to the higher IG retention rates may be the opportunity presented to
the researcher to build rapport during the physical activity consultation process. The
importance of building rapport with eligible individuals can often be underestimated,
however, gaining trust and showing empathy particularly towards at risk populations
may contribute positively to recruitment and retention rates. The use of motivational
interviewing, a participant centred behaviour change technique, with at-risk populations
is one approach that has received much attention in recent years [33–35] and was applied
within this RCT. A recent review [30] reported the mean retention rate of a South Asian
ethnic minority population to behavioural interventions aimed at reducing type 2 diabetes
was 79.4% across all 14 studies examined. However, these researchers highlighted that
unstandardised and inconsistent reporting limited their ability to draw any conclusions
regarding the best strategies to maximise recruitment and retention [30] reinforcing the
need for researchers to sufficiently report recruitment strategies and retention methods
and rates.
It is evident that individuals at risk of developing type 2 diabetes do not engage in
adequate physical activity [6] and a minority of this population (<55%) have reported
completing current physical activity guidelines for health [36]. Once participants have
been recruited and randomised into a physical activity RCT, ensuring this typically inac-
tive population achieve and maintain the prescribed activity is another challenge facing
researchers and clinicians. Willenger and colleagues [20] concluded that adoption (an
individual’s uptake of physical activity at recommended levels) and maintenance (long-
term behaviour change) rates were rarely reported within physical activity interventions.
In the current study IG walking compliance (volume and duration) was highest in the
first four months of the study (70.1 ± 39.2%) after which a decrease was observed at each
assessment point. One suggestion may be that as behavioural change support techniques
were tapered as the study progressed, particularly after four months, this may have had a
direct impact on IG walking compliance. Current physical activity guidelines recommend
that physical activity should be at least moderate intensity to elicit health benefits [27].
A common issue facing researchers seeking to promote physical activity guidelines for
health is ensuring that participants can self-regulate physical activity intensity in free-living
environments. Interestingly, ≥71.4% of walking completed was at least moderate intensity
(predetermined target cadence) throughout this nine-month study. These latter results
suggest walking to music with a predetermined individualised tempo may provide a novel
method that enables this population to achieve at least moderate intensity activity in a
free-living environment.
Limitations
This study has a number of limitations. Although this study met its target sample
size, it included a relatively small number of overall participants (N = 42). Therefore,
generalisability of its results to larger populations should be cautioned. This research
should be replicated in larger scale studies which include greater sample sizes. This
study recruited participants from within Northern Ireland, replication of this intervention
within other countries and including a broader range of demographics, e.g., ethnicity and
socioeconomic characteristics, should be considered by future research. The compliance of
these populations to the walking intervention and the effects on health outcomes within
larger sample sizes also merits further study. As discussed previously the value of an on-
campus or on-site researcher led recruitment appears to be the most productive recruitment
strategy. Likely in part due to the opportunity presented to firstly identify and then build
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rapport and motivate potential participants. The current study had one researcher on-
campus performing this role. While it is appreciated that resources are often a limiting
factor, if a team of researchers were available to complete this role in future studies, perhaps
the pool of potential participants targeted and identified would be larger resulting in a
greater sample size.
5. Conclusions
This work explores the effectiveness of various recruitment strategies, study retention
rates and walking compliance within the nine-month free-living RCT. This research high-
lights the issues surrounding identification of undiagnosed adults at risk of developing
type 2 diabetes. Study retention rates were explored, and results suggest that the use of
novel techniques, i.e., music and technology coupled with behaviour change techniques
and skills such as purposefully gaining trust and displaying empathy, may positively affect
the retention of intervention and control group participants. As recruitment and retention
of this overweight IHG population remains a global challenge future studies should aim
to replicate the use of this novel intervention, using individualised music and behaviour
change support, to examine its effects on larger sample sizes with varying demographics,
e.g., ethnicity and socioeconomic status. Compliance of these populations to the novel
walking intervention and its resultant effects on health outcomes also merit further study.
In conclusion, there is a need for participant recruitment strategies, study retention and
intervention compliance rates to be reliably reported by researchers to encourage successful
delivery of physical activity interventions aimed at managing IHG and reducing the
incidence of type 2 diabetes. It is generally accepted that populations at risk of developing
type 2 diabetes, i.e., overweight inactive adults with IHG, are a cohort that are initially
quite difficult to identify and then challenging to recruit, engage and retain in research.
Consistent reporting and publication of this information will ensure research is guided and
underpinned by the most efficient strategies.
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